BRISTOL-MYERS SQUIBB CO (BMY) Stock Price, Quote, News and Overview
NYSE:BMY - New York Stock Exchange, Inc. - US1101221083 - Common Stock - Currency: USD
BMY Quote, Performance and Key Statistics
BRISTOL-MYERS SQUIBB CO
NYSE:BMY (1/24/2025, 8:27:55 PM)
After market: 59.9999 +0.33 (+0.55%)59.67
+0.53 (+0.9%)
The current stock price of BMY is 59.67 USD. In the past month the price increased by 3.63%. In the past year, price increased by 20.06%.
BMY Latest News, Press Releases and Analysis
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, despite investor concerns over M&A and deals.
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NASDAQ:GILD),(NYSE:BMY) EQNX::TICKER_END
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Bristol Myers Says New Schizophrenia Drug Off to Strong Start
Bristol Myers Squibb Co. said its new schizophrenia drug is off to a better start than similar recently launched treatments, in an early sign that its $14 billion purchase of Karuna Therapeutics is paying off.
BMY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 77.23 | 745.61B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 29.42 | 390.70B | ||
| JNJ | JOHNSON & JOHNSON | 14.7 | 353.49B | ||
| MRK | MERCK & CO. INC. | 16.06 | 241.71B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.13 | 214.16B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.4 | 199.87B | ||
| PFE | PFIZER INC | 10.11 | 147.85B | ||
| SNY | SANOFI-ADR | 12.5 | 131.58B | ||
| ZTS | ZOETIS INC | 29.27 | 76.07B | ||
| GSK | GSK PLC-SPON ADR | 8.28 | 69.92B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.65 | 41.18B | ||
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 7.8 | 24.56B |
Related stock screener links
About BMY
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees. The company offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The firm's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.
Company Info
BRISTOL-MYERS SQUIBB CO
Route 206 And Province Line Road
Princeton NEW JERSEY 10016 US
CEO: Giovanni Caforio
Employees: 34100
Company Website: https://www.bms.com/
Investor Relations: https://www.bms.com/investors.html
Phone: 16092524621
BMY FAQ
What is the stock price of BMY?
The current stock price of BMY is 59.67 USD.
What is the symbol for BRISTOL-MYERS SQUIBB CO stock?
The exchange symbol of BRISTOL-MYERS SQUIBB CO is BMY and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is BMY stock listed?
BMY stock is listed on the New York Stock Exchange, Inc. exchange.
Is BMY a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BMY, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BMY.
Does BMY stock pay dividends?
BMY has a dividend yield of 4.19%. The yearly dividend amount is currently 2.32.
When does BMY stock report earnings?
BMY will report earnings on 2025-02-06, after the market close.
What is the Price/Earnings (PE) ratio of BMY?
The PE ratio for BMY is 51. This is based on the reported non-GAAP earnings per share of 1.17 and the current share price of 59.67 USD.
What is the Short Interest ratio of BMY stock?
The outstanding short interest for BMY is 1.23% of its float.
BMY Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to BMY. When comparing the yearly performance of all stocks, BMY is one of the better performing stocks in the market, outperforming 78.67% of all stocks.
BMY Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BMY. BMY has only an average score on both its financial health and profitability.
BMY Financial Highlights
Over the last trailing twelve months BMY reported a non-GAAP Earnings per Share(EPS) of 1.17. The EPS increased by -84.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.75% | ||
| ROE | -42.34% | ||
| Debt/Equity | 2.85 |
BMY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 69% to BMY. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of -87.61% and a revenue growth 6.98% for BMY